Copperwynd Financial, LLC Novo Nordisk A S Transaction History
Copperwynd Financial, LLC
- $361 Million
- Q4 2024
A detailed history of Copperwynd Financial, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Copperwynd Financial, LLC holds 8,068 shares of NVO stock, worth $664,238. This represents 0.19% of its overall portfolio holdings.
Number of Shares
8,068
Previous 7,418
8.76%
Holding current value
$664,238
Previous $883,000
21.4%
% of portfolio
0.19%
Previous 0.27%
Shares
5 transactions
Others Institutions Holding NVO
# of Institutions
1,876Shares Held
336MCall Options Held
11.9MPut Options Held
10.6M-
Jennison Associates LLC19.9MShares$1.64 Billion1.06% of portfolio
-
Bank Of America Corp Charlotte, NC15.5MShares$1.28 Billion0.11% of portfolio
-
Gqg Partners LLC Ft. Lauderdale, FL13MShares$1.07 Billion1.67% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa12.6MShares$1.04 Billion0.44% of portfolio
-
Morgan Stanley New York, NY12.2MShares$1 Billion0.08% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $186B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...